HealthFinSMEsabout 3 hours ago
Celaid Therapeutics Secures Series B Funding Round
1 min read
Celaid Therapeutics, a Tokyo-based biotechnology startup, successfully raised approximately USD 2.6 million in the second close of its Series B funding. This brings the total raised to about USD 22.1 million, which will support clinical development and IND application.
Level
Hype check
Tap to vote and see what everyone thinks.
